Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EP300: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
EP300 is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, regulates. Associated with Aging, Als, Alzheimer. Connected to 390 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | EP300 |
| Chromosome | 22q13.2 |
| Protein Type | Transferase |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | Ubiquitous, highest in brain |
| Molecular Weight | 300 kDa |
| Amino Acids | 414 aa |
| Pathways | NF-κB |
| GeneCards | EP300 |
| Human Protein Atlas | EP300 |
| Associated Diseases | Als, Alzheimer, Autoimmune, Cancer, Carcinoma |
| Known Drugs/Compounds | Acetyl-CoA, rapamycin |
| Interactions | ACAT1, AMPK, AND, ATG, AUTOPHAGY, BRD4 |
| KG Connections | 575 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
EP300["EP300"] -->|"Regulates"| histone_H2B_acetylation["histone H2B acetylation"]
EP300["EP300"] -->|"Associated With"| Tumor["Tumor"]
EP300["EP300"] -->|"Associated With"| Parkinson["Parkinson"]
EP300["EP300"] -->|"Therapeutic Target"| Glioblastoma["Glioblastoma"]
EP300["EP300"] -->|"Therapeutic Target"| Cancer["Cancer"]
EP300["EP300"] -->|"Therapeutic Target"| Ms["Ms"]
EP300["EP300"] -->|"Therapeutic Target"| Fibrosis["Fibrosis"]
EP300["EP300"] -->|"Therapeutic Target"| Hepatitis["Hepatitis"]
OPTN["OPTN"] -->|"Associated With"| EP300["EP300"]
ULK1["ULK1"] -->|"Associated With"| EP300["EP300"]
CALCOCO2["CALCOCO2"] -->|"Associated With"| EP300["EP300"]
HSPA8["HSPA8"] -->|"Associated With"| EP300["EP300"]
STX17["STX17"] -->|"Associated With"| EP300["EP300"]
style EP300 fill:#8d4900,color:#e0e0e0
style histone_H2B_acetylation fill:#1b5e20,color:#e0e0e0
style Tumor fill:#b71c1c,color:#e0e0e0
style Parkinson fill:#b71c1c,color:#e0e0e0
style Glioblastoma fill:#b71c1c,color:#e0e0e0
style Cancer fill:#b71c1c,color:#e0e0e0
style Ms fill:#b71c1c,color:#e0e0e0
style Fibrosis fill:#b71c1c,color:#e0e0e0
style Hepatitis fill:#b71c1c,color:#e0e0e0
style OPTN fill:#8d4900,color:#e0e0e0
style ULK1 fill:#8d4900,color:#e0e0e0
style CALCOCO2 fill:#8d4900,color:#e0e0e0
style HSPA8 fill:#8d4900,color:#e0e0e0
style STX17 fill:#8d4900,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Histone Acetylation | regulates | process | 0.90 |
| RPTOR | phosphorylates | protein | 0.85 |
| ESR1 | interacts_with | protein | 0.80 |
| Cancer | therapeutic_target | disease | 0.75 |
| Cancer | expressed_in | disease | 0.75 |
| Tumor | expressed_in | disease | 0.75 |
| SIRT1 | interacts_with | gene | 0.70 |
| histone H2B acetylation | regulates | process | 0.70 |
| epigenetic regulation | participates_in | pathway | 0.70 |
| MAPK signaling | participates_in | pathway | 0.70 |
| Als | regulates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Hypertension | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Schizophrenia | interacts_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Hepatitis | associated_with | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Diabetes | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Autoimmune | associated_with | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Leukemia | activates | disease | 0.65 |
| Migraine | associated_with | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Leukemia | therapeutic_target | disease | 0.65 |
| Glioblastoma | associated_with | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Glioblastoma | therapeutic_target | disease | 0.65 |
| PI3K | co_discussed | gene | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Dementia | interacts_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Obesity | associated_with | disease | 0.65 |
| Stroke | associated_with | disease | 0.65 |
| Multiple Sclerosis | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Leukemia | associated_with | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| STAT3 | co_discussed | gene | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CBX3 | interacts_with | protein | 0.93 |
| CBX3 | binds | gene | 0.90 |
| Acetyl-CoA | activates | compound | 0.90 |
| CANCER | expressed_in | gene | 0.70 |
| P53 | expressed_in | gene | 0.70 |
| AKT | co_discussed | gene | 0.65 |
| HDAC6 | associated_with | gene | 0.60 |
| LYSOSOME | regulates | gene | 0.60 |
| CREBBP | associated_with | gene | 0.60 |
| AMPK | activates | entity | 0.60 |
| ATG | associated_with | gene | 0.60 |
| NATURAL COMPOUNDS | protects_against | gene | 0.60 |
| ALZHEIMER | protects_against | gene | 0.60 |
| CREB | associated_with | gene | 0.60 |
| GENES | contributes_to | gene | 0.60 |
| APOPTOSIS | associated_with | gene | 0.60 |
| GSK3 | associated_with | gene | 0.60 |
| P53 | associated_with | gene | 0.60 |
| RUBCNL | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| AND | activates | gene | 0.60 |
| GLIOBLASTOMA | activates | gene | 0.60 |
| MAPK | interacts_with | gene | 0.60 |
| AMPK | associated_with | gene | 0.60 |
| ACAT1 | activates | gene | 0.60 |
| ATG | activates | gene | 0.60 |
| CREB | activates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| AND | interacts_with | gene | 0.60 |
| CREB | interacts_with | gene | 0.60 |
| DNA | expressed_in | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| AKT | targets | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| CALCOCO2 | associated_with | gene | 0.60 |
| HSPA8 | associated_with | gene | 0.60 |
| STX17 | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| KAT8 | associated_with | gene | 0.60 |
| RB1CC1 | associated_with | gene | 0.60 |
| SIRT1 | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| SNAP29 | associated_with | gene | 0.60 |
| RB1 | associated_with | gene | 0.60 |
| KAT2B | associated_with | gene | 0.60 |
| KAT5 | associated_with | gene | 0.60 |
| WIPI2 | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| EGFR | targets | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning EP300 in their description or question text
No additional research found